Literature DB >> 12626790

Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment.

E Nordborg1, C Nordborg.   

Abstract

Giant cell arteritis (GCA) is a chronic systemic vasculitis with a marked female predominance and restriction to old age. The disease process distinctly targets large and medium sized arteries, preferentially the aorta and its extracranial branches. Morphological observations indicate that the age and sex distribution of GCA is related to the occurrence of degenerative changes in the arterial wall. GCA is not a truly infectious vasculitis. However, an infection might be a triggering factor. Different centres report an increase in GCA incidence, but annual fluctuations have not been shown to be statistically significant. However, significant seasonal variations have been observed by several groups. The mortality is not increased in adequately treated patients. Although, alternative steroid-sparing agents have been proposed, corticosteroids are still the first treatment choice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626790     DOI: 10.1093/rheumatology/keg116

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  21 in total

1.  Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Charat Thongprayoon; Kenneth J Warrington
Journal:  Ann Transl Med       Date:  2015-09

2.  Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis.

Authors:  K Larsson; D Mellström; E Nordborg; C Nordborg; A Odén; E Nordborg
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

3.  Epidemiology of giant cell arteritis in an Arab population: a 22-year study.

Authors:  Neil R Miller
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

4.  Giant cell arteritis as a cardiovascular entity.

Authors:  P Houthuizen; P E Polak; M A L Edelbroek; C H Peels
Journal:  Neth Heart J       Date:  2009-08       Impact factor: 2.380

Review 5.  Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management.

Authors:  Alvise Berti; Roberto Caporali; Carlomaurizio Montecucco; Giuseppe Paolazzi; Sara Monti
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

Review 6.  An update on the role of epigenetics in systemic vasculitis.

Authors:  Patrick Coit; Haner Direskeneli; Amr H Sawalha
Journal:  Curr Opin Rheumatol       Date:  2018-01       Impact factor: 5.006

Review 7.  Role of NADPH oxidase in formation and function of multinucleated giant cells.

Authors:  Mark T Quinn; Igor A Schepetkin
Journal:  J Innate Immun       Date:  2009-07-07       Impact factor: 7.349

Review 8.  [Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment].

Authors:  T Ness; C Auw-Hädrich; D Schmidt
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

Review 9.  Current Controversies in Large-Vessel Inflammatory Vasculitis and Thoracic Aortic Aneurysm Disease.

Authors:  Amer Harky; Matthew Fok; Callum Howard; Mohamad Bashir
Journal:  Int J Angiol       Date:  2019-06-28

10.  Body mass index and the risk of giant cell arteritis: results from a prospective study.

Authors:  Karin Jakobsson; Lennart Jacobsson; Kenneth Warrington; Eric L Matteson; Kimberly Liang; Olle Melander; Carl Turesson
Journal:  Rheumatology (Oxford)       Date:  2014-09-05       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.